Monogram Technologies to Host Second Quarter 2024 Business Update Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time
Monogram Technologies (NASDAQ:MGRM), an AI-driven robotics company focused on orthopedic surgery, has announced a business update conference call scheduled for August 14, 2024, at 4:30 p.m. Eastern Time. The call will coincide with the release of the company's financial results for Q2 2024, ending June 30. CEO Ben Sexson and CFO Noel Knape will host the call, which will include a presentation and a Q&A session.
Investors can access the call through a registration link provided by the company. The presentation will be available for viewing during the webcast and can also be accessed via Monogram's investor relations website. A press release detailing the financial results will be issued prior to the call.
Monogram Technologies (NASDAQ:MGRM), un azienda di robotica guidata dall'IA focalizzata sulla chirurgia ortopedica, ha annunciato una videochiamata di aggiornamento aziendale prevista per 14 agosto 2024, alle 16:30 ora orientale. La chiamata coinciderà con la pubblicazione dei risultati finanziari per il secondo trimestre del 2024, che si chiude il 30 giugno. Il CEO Ben Sexson e il CFO Noel Knape ospiteranno la chiamata, che includerà una presentazione e una sessione di domande e risposte.
Gli investitori possono accedere alla chiamata tramite un link di registrazione fornito dall'azienda. La presentazione sarà disponibile per la visione durante il webcast e potrà essere consultata anche sul sito delle relazioni con gli investitori di Monogram. Un comunicato stampa contenente i risultati finanziari verrà rilasciato prima della chiamata.
Monogram Technologies (NASDAQ:MGRM), una empresa de robótica impulsada por IA centrada en la cirugía ortopédica, ha anunciado una videollamada de actualización empresarial programada para 14 de agosto de 2024, a las 4:30 p.m. Hora del Este. La llamada coincidirá con la publicación de los resultados financieros del segundo trimestre de 2024, que finaliza el 30 de junio. El CEO Ben Sexson y el CFO Noel Knape serán los anfitriones de la llamada, que incluirá una presentación y una sesión de preguntas y respuestas.
Los inversores pueden acceder a la llamada a través de un enlace de registro proporcionado por la empresa. La presentación estará disponible para su visualización durante el webcast y también se podrá acceder a través del sitio web de relaciones con inversores de Monogram. Se emitirá un comunicado de prensa con los resultados financieros antes de la llamada.
Monogram Technologies (NASDAQ:MGRM), AI 기반 로봇 공학 회사로 정형외과 수술에 중점을 두고 있는 이 회사는 2024년 8월 14일 동부 표준시 오후 4시 30분에 예정된 사업 업데이트 컨퍼런스 콜를 발표했습니다. 이 전화회의는 회사의 2024년 2분기 재무 결과 발표와 동시에 진행됩니다. CEO Ben Sexson과 CFO Noel Knape가 전화 회의를 주최하며, 발표와 질의응답 세션이 포함됩니다.
투자자는 회사에서 제공하는 등록 링크를 통해 전화 회의에 참여할 수 있습니다. 발표는 웹캐스트 중에 시청할 수 있으며, Monogram의 투자자 관계 웹사이트를 통해서도 접근할 수 있습니다. 재무 결과에 대한 보도자료는 전화 회의 전에 배포될 예정입니다.
Monogram Technologies (NASDAQ:MGRM), une entreprise de robotique pilotée par IA axée sur la chirurgie orthopédique, a annoncé une conférence téléphonique de mise à jour commerciale prévue pour le 14 août 2024 à 16h30, heure de l'Est. L'appel coïncidera avec la publication des résultats financiers du deuxième trimestre 2024, se terminant le 30 juin. Le PDG Ben Sexson et le directeur financier Noel Knape animeront l'appel, qui comprendra une présentation et une session de questions-réponses.
Les investisseurs peuvent accéder à l'appel via un lien d'inscription fourni par l'entreprise. La présentation sera disponible pour visionnage pendant le webinaire et pourra également être consultée via le site de relations avec les investisseurs de Monogram. Un communiqué de presse détaillant les résultats financiers sera publié avant l'appel.
Monogram Technologies (NASDAQ:MGRM), ein KI-gesteuertes Robotikunternehmen, das sich auf orthopädische Chirurgie konzentriert, hat eine Telefonkonferenz zur Unternehmensaktualisierung für 14. August 2024, um 16:30 Uhr Eastern Time angekündigt. Der Anruf fällt mit der Veröffentlichung der Finanzergebnisse für das zweite Quartal 2024 zusammen, das am 30. Juni endet. CEO Ben Sexson und CFO Noel Knape werden die Konferenz leiten, die eine Präsentation und eine Frage-Antwort-Runde umfasst.
Investoren können über einen von der Firma bereitgestellten Anmeldelink auf die Konferenz zugreifen. Die Präsentation wird während des Webcasts verfügbar sein und kann auch über die Website der Investor Relations von Monogram aufgerufen werden. Eine Pressemitteilung mit den Finanzergebnissen wird vor der Konferenz veröffentlicht.
- None.
- None.
AUSTIN, TX / ACCESSWIRE / August 1, 2024 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company focused on improving human health with an initial focus on orthopedic surgery, will hold a business update conference call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time in conjunction with its reported financial results for the second quarter ended June 30, 2024 and to discuss key milestones. A press release detailing these results will be issued prior to the call.
Monogram CEO Ben Sexson and CFO Noel Knape will host the conference call, followed by a question-and-answer session. The conference call will be accompanied by a presentation, which can be viewed during the webcast or accessed via the investor relations section of the Company's website here.
To access the call, please use the following information:
Date: | Wednesday, August 14, 2024 |
Time: | 4:30 p.m. Eastern time (1:30 p.m. Pacific time) |
Registration Link: |
The conference call will be broadcast live and available for replay to those who register via the above registration link.
About Monogram Technologies Inc.
Monogram Technologies (NASDAQ:MGRM) is an AI-driven robotics company focused on improving human health, with an initial focus on orthopedic surgery. The Company is developing a product solution architecture to enable patient-optimized orthopedic implants at scale by combining 3D printing, advanced machine vision, AI and next-generation robotics.
Monograms mBôs precision robotic surgical system is designed to autonomously execute optimized paths for high-precision insertion of its FDA-cleared mPress press-fit implants. The goal is well balanced better-fitting bone sparing knee replacements. The Company initially intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. Other clinical and commercial applications for the mBôs with mVision navigation are also being explored.
Monogram has obtained FDA clearance for mPress implants. Monogram currently plans to apply for 510(k) clearance for its robotic products in the second half of 2024. The Company is required to obtain FDA clearance before it can market its products. Monogram cannot estimate the timing or assure the ability to obtain such clearances.
The Company believes that its mBôs precision robotic surgical assistants, which combine AI and novel navigation methods (mVision), will enable more personalized knee implants for patients, resulting in well balanced better-fitting knee replacements with bone sparing implants. Monogram anticipates that there may be other clinical and commercial applications for its navigated mBôs precision robot and mVision navigation.
To learn more, visit monogramtechnologies.com.
Forward-Looking Statements
This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements other than statements of historical facts included in this press release may constitute forward-looking statements and are not guarantees of future performance or results and involve a number of risks and uncertainties. For example, the Company's statement regarding the Company's proposed use of net proceeds is a forward-looking statement. Forward-looking statements, other than statements of historical fact, are highly likely to be affected by other unknowable future events and conditions, including elements of the future that are or are not under our control, and that the Company may or may not have considered; accordingly, such statements cannot be guarantees or assurances of any aspect of future performance. Actual developments and results are highly likely to vary materially from any forward-looking statements as a result of a number of factors, including those described in the prospectus and the Company's other filings with the SEC. The Company undertakes no duty to update any forward-looking statement made herein. All forward-looking statements speak only as of the date of this press release.
Investor Relations
Chris Tyson
Executive Vice President
MZ North America
Direct: 949-491-8235
MGRM@mzgroup.us
SOURCE: Monogram Technologies Inc.
View the original press release on accesswire.com
FAQ
When is Monogram Technologies (MGRM) hosting its Q2 2024 business update call?
Who will be hosting Monogram Technologies' (MGRM) Q2 2024 earnings call?
How can investors access Monogram Technologies' (MGRM) Q2 2024 earnings call?
What period does Monogram Technologies' (MGRM) Q2 2024 financial results cover?
